---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-004125"
form_type: "8-K"
ticker: "EVTV"
cik: "0001563568"
company_name: "Envirotech Vehicles, Inc."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:46:38.686390+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# EVTV loses Nasdaq independence compliance, gets cure; regains annual meeting rule compliance

## Summary
- Director Melissa Barcellos resigned effective Feb 3, 2026, causing non-compliance with Nasdaq board independence and audit committee composition rules.
- Cure period granted: must comply by earlier of next annual meeting or Feb 3, 2027 (or Aug 3, 2026 if next meeting before that).
- Company plans to add a new independent director to regain compliance within the cure period.
- Regained compliance with Nasdaq annual meeting rule (5620(a)) after holding 2025 annual meeting on Feb 3, 2026; matter closed.

## SEC filing metadata
- accession: 0001437749-26-004125
- form_type: 8-K
- ticker: EVTV
- cik: 0001563568
- company_name: Envirotech Vehicles, Inc.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563568/000143774926004125/0001437749-26-004125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563568/000143774926004125/adom20260213_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-004125
- JSON: https://secwatch.observer/filing/0001437749-26-004125.json
- Plain text: https://secwatch.observer/filing/0001437749-26-004125.txt

## Key facts
- Listing & Compliance Notices
  Envirotech Vehicles, Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: board independence
  - Rules: 5605(b)(1), 5605(c)(2)(A)
  source text: February 12, 2026, the Company received a notice from the Listing Qualifications Department of Nasdaq confirming the availability of the cure period under Nasdaq Listing Rule 5605(b)(1)(A) and Nasdaq Listing Rule 5605(c)(4), permitting the Company to regain compliance with Nasdaq Listing Rule 5605(b)(1) and Nasdaq Listing Rule 5605(c)(2)(A) by the earlier of the Company’s next annual meeting of stockholders or February 3, 2027, or, if the next annual meeting of stockholders is held before August 3, 2026, then the Company must evidence compliance no later than August 3, 2026. The Company intend
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563568/000143774926004125/0001437749-26-004125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.